141 related articles for article (PubMed ID: 16556703)
21. Macular oedema following rituximab infusion in two patients with Wegener's granulomatosis.
Bussone G; Kaswin G; de Menthon M; Delair E; Brézin AP; Guillevin L
Clin Exp Rheumatol; 2010; 28(1 Suppl 57):90-2. PubMed ID: 20412711
[TBL] [Abstract][Full Text] [Related]
22. Does Concomitant Methotrexate During Rituximab Treatment in Granulomatosis With Polyangiitis (Wegener's) Increase the Risk of Severe Infection? Comment on the Article by Azar et al.
Besada E; Diamantopoulos AP
Arthritis Rheumatol; 2015 Jul; 67(7):1981-2. PubMed ID: 25892609
[No Abstract] [Full Text] [Related]
23. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients.
Calich AL; Puéchal X; Pugnet G; London J; Terrier B; Charles P; Mouthon L; Guillevin L;
J Autoimmun; 2014 May; 50():135-41. PubMed ID: 24703438
[TBL] [Abstract][Full Text] [Related]
24. Advances in the therapy of Wegener's granulomatosis.
Hellmich B; Lamprecht P; Gross WL
Curr Opin Rheumatol; 2006 Jan; 18(1):25-32. PubMed ID: 16344616
[TBL] [Abstract][Full Text] [Related]
25. Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab.
Eriksson P
J Intern Med; 2005 Jun; 257(6):540-8. PubMed ID: 15910558
[TBL] [Abstract][Full Text] [Related]
26. Anti-CD20 therapy of treatment-resistant Wegener's granulomatosis: favourable but temporary response.
Omdal R; Wildhagen K; Hansen T; Gunnarsson R; Kristoffersen G
Scand J Rheumatol; 2005; 34(3):229-32. PubMed ID: 16134730
[TBL] [Abstract][Full Text] [Related]
27. Rituximab in refractory ophthalmic Wegener's granulomatosis: PR3 titers may predict relapse, but repeat treatment can be effective.
Joshi L; Lightman SL; Salama AD; Shirodkar AL; Pusey CD; Taylor SR
Ophthalmology; 2011 Dec; 118(12):2498-503. PubMed ID: 21907416
[TBL] [Abstract][Full Text] [Related]
28. [Rituximab for treatment of patients with systemic autoimmune diseases].
García Hernández FJ; Ocaña Medina C; González León R; Garrido Rasco R; Colorado Bonilla R; Castillo Palma MJ; Sánchez Román J
Med Clin (Barc); 2007 Mar; 128(12):458-62. PubMed ID: 17408540
[TBL] [Abstract][Full Text] [Related]
29. Maintaining remission in a patient with vasculitis.
Flossmann O; Jayne DR
Nat Clin Pract Rheumatol; 2008 Sep; 4(9):499-504. PubMed ID: 18648340
[TBL] [Abstract][Full Text] [Related]
30. Wegener's granulomatosis effectively treated with rituximab: a case study.
Kowalewska B; Szechiński J; Roszkowska E
Pol Arch Med Wewn; 2008 Jun; 118(6):381-5. PubMed ID: 18619196
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment of gynaecological involvement of granulomatosis with polyangiitis (Wegener's granulomatosis) by rituximab.
Bastone P; Squifflet JL; Marbaix E; Houssiau F
Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-142-4. PubMed ID: 26016766
[TBL] [Abstract][Full Text] [Related]
32. Relapsed Wegener's granulomatosis after rituximab therapy--B cells are present in new pathological lesions despite persistent 'depletion' of peripheral blood.
Ferraro AJ; Smith SW; Neil D; Savage CO
Nephrol Dial Transplant; 2008 Sep; 23(9):3030-2. PubMed ID: 18586761
[TBL] [Abstract][Full Text] [Related]
33. Successful therapeutic use of rituximab in refractory Wegener's granulomatosis after renal transplantation.
Hermle T; Goestemeyer AK; Sweny P; Burns A
Clin Nephrol; 2007 Nov; 68(5):322-6. PubMed ID: 18044265
[TBL] [Abstract][Full Text] [Related]
34. Rituximab in the treatment of refractory scleritis in patients with granulomatosis with polyangiitis (Wegener's).
Recillas-Gispert C; Serna-Ojeda JC; Flores-Suárez LF
Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2279-84. PubMed ID: 26507398
[TBL] [Abstract][Full Text] [Related]
35. Rituximab for refractory Wegener's granulomatosis.
Antoniu SA
Expert Opin Investig Drugs; 2006 Sep; 15(9):1115-7. PubMed ID: 16916277
[TBL] [Abstract][Full Text] [Related]
36. Wegener granulomatosis with massive intracerebral hemorrhage: remission of disease in response to rituximab.
Memet B; Rudinskaya A; Krebs T; Oelberg D
J Clin Rheumatol; 2005 Dec; 11(6):314-8. PubMed ID: 16371801
[TBL] [Abstract][Full Text] [Related]
37. Analysis of Wegener's granulomatosis responses to rituximab: current evidence and therapeutic prospects.
Aouba A; Pagnoux C; Bienvenu B; Mahr A; Guillevin L
Clin Rev Allergy Immunol; 2008 Feb; 34(1):65-73. PubMed ID: 18270860
[TBL] [Abstract][Full Text] [Related]
38. Rituximab Induction and Maintenance Treatment in Patients with Scleritis and Granulomatosis with Polyangiitis (Wegener's).
You C; Ma L; Lasave AF; Foster CS
Ocul Immunol Inflamm; 2018; 26(8):1166-1173. PubMed ID: 28628344
[TBL] [Abstract][Full Text] [Related]
39. [Treatment with rituximab of autoimmune disease: results from AADEA's registry].
Callejas Rubio JL; Camps MT; García-Hernández F;
Med Clin (Barc); 2008 Jan; 130(2):79. PubMed ID: 18221681
[No Abstract] [Full Text] [Related]
40. Effects of anti-CD20 monoclonal antibody as a rescue treatment for ANCA-associated idiopathic systemic vasculitis with or without overt renal involvement.
Roccatello D; Baldovino S; Alpa M; Rossi D; Napoli F; Naretto C; Cavallo R; Giachino O
Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S67-71. PubMed ID: 18799057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
